Thomas R.Cushing (Dan)

Associate

(T) 1.214.969.4527

Dan Cushing's practice focuses on defending clients in high-profile matters related to allegations of securities fraud and international corruption. His experience includes conducting internal investigations in both foreign and domestic markets, advising clients on regulatory compliance issues, defending against government investigations, and defending against parallel litigation such as shareholder derivative and insurer claims.

Dan has represented numerous companies and their audit committees in connection with internal investigations relating to alleged FCPA violations, accounting fraud, disclosure issues, commercial bribery, and insider trading. He has extensive experience with defending clients in securities fraud class actions, shareholder derivative actions, and SEC enforcement investigations. He also assists companies with regulatory compliance issues related to international anticorruption laws, acquisition due diligence, and data privacy.

In addition to his securities experience, Dan has significant experience with corporate criminal and white collar litigation, including defending both corporations and individuals in federal and state criminal actions. Dan's experience in this area includes defending companies and individuals from allegations related to environmental crimes in the United States as well as foreign jurisdictions.

Dan also has strong experience in dealing with banking and finance litigation and associated regulatory actions, energy litigation, construction litigation, and litigation arising in the context of mergers and acquisitions.

Dan is an active member of the State Bar of Texas and the Dallas Bar Association and maintains a strong presence in several national and local charitable organizations.

Experience

  • Evidera acquires MedimixJones Day advised Evidera, a business unit of Pharmaceutical Product Development, LLC, in its acquisition of Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic, and medical device industries.
  • Granite Construction acquires Layne Christensen for $536 million stock mergerJones Day advised Granite Construction Incorporated in its $536 million stock-for-stock acquisition of Layne Christensen Company, a global water management, construction, and drilling company.
  • Major multinational corporation undergoes internal investigation into accounting fraud and corruptionJones Day conducted an internal investigation into alleged accounting fraud and corruption in the international operations of a major publicly traded multinational corporation.
  • Former president of foreign subsidiary defends against investigation by SECJones Day is representing the former president of a foreign subsidiary of a Fortune 500 company in connection with an investigation by the Securities and Exchange Commission into allegations of improper revenue recognition and accounting fraud.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.